Mill Creek Capital Advisors, LLC Adagene Inc. Transaction History
Mill Creek Capital Advisors, LLC
- $4.09 Billion
- Q3 2024
A detailed history of Mill Creek Capital Advisors, LLC transactions in Adagene Inc. stock. As of the latest transaction made, Mill Creek Capital Advisors, LLC holds 90,908 shares of ADAG stock, worth $176,361. This represents 0.0% of its overall portfolio holdings.
Number of Shares
90,908Holding current value
$176,361% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADAG
# of Institutions
13Shares Held
9.87MCall Options Held
0Put Options Held
0-
Wu Xi App Tec Co., Ltd. Shanghai, F43.98MShares$7.73 Million46.44% of portfolio
-
Fil LTD Hamilton, D03.6MShares$6.98 Million0.01% of portfolio
-
Sc China Holding LTD N/A, K31.34MShares$2.61 Million0.11% of portfolio
-
General Atlantic LLC New York, NY264KShares$512,1600.02% of portfolio
-
Exome Asset Management LLC New York, NY263KShares$509,4920.4% of portfolio
About Adagene Inc.
- Ticker ADAG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,423,200
- Market Cap $84.2M
- Description
- Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...